Nuclear Medicine Market Professional Survey Report 2018

Nuclear Medicine report studies the global Nuclear Medicine market status and forecast, categorizes the global Nuclear Medicine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/global-nuclear-medicine-2018-747

The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.

Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.

The global Nuclear Medicine market is valued at 4590 million US$ in 2017 and will reach 7580 million US$ by the end of 2025, growing at a CAGR of 7.4% during 2018-2025.

The major manufacturers covered in this report

GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Geographically, Nuclear Medicine report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
By Application, the market can be split into

Diagnostic
Therapeutic
The study objectives of this report are:

To analyze and study the global Nuclear Medicine capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Nuclear Medicine manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Nuclear Medicine are as follows:

History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Nuclear Medicine Manufacturers
Nuclear Medicine Distributors/Traders/Wholesalers
Nuclear Medicine Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, We offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Nuclear Medicine market, by end-use.

Detailed analysis and profiles of additional market players.

Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/global-nuclear-medicine-2018-747

Table of content
Global Nuclear Medicine Market Professional Survey Report 2018
1 Industry Overview of Nuclear Medicine
1.1 Definition and Specifications of Nuclear Medicine
1.1.1 Definition of Nuclear Medicine
1.1.2 Specifications of Nuclear Medicine
1.2 Classification of Nuclear Medicine
1.2.1 Tc-99
1.2.2 I-123/131
1.2.3 In-111
1.2.4 Xe-133
1.2.5 Th-201
1.2.6 Ga-67
1.2.7 Other
1.3 Applications of Nuclear Medicine
1.3.1 Diagnostic
1.3.2 Therapeutic
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Nuclear Medicine
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine
2.3 Manufacturing Process Analysis of Nuclear Medicine
2.4 Industry Chain Structure of Nuclear Medicine

3 Technical Data and Manufacturing Plants Analysis of Nuclear Medicine
3.1 Capacity and Commercial Production Date of Global Nuclear Medicine Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Nuclear Medicine Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Nuclear Medicine Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Nuclear Medicine Major Manufacturers in 2017

If You Have Any Question Related To This Report Contact Us @ https://www.24marketreports.com/enquire-now/global-nuclear-medicine-2018-747

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: help@24marketreports.com

Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports